These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The potential for bias in reporting of industry-sponsored clinical trials. Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037 [TBL] [Abstract][Full Text] [Related]
3. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730 [TBL] [Abstract][Full Text] [Related]
4. Commentary: Professional responsibilities. Jacobs A Pharm Stat; 2011; 10(1):82. PubMed ID: 21275039 [No Abstract] [Full Text] [Related]
5. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020 [TBL] [Abstract][Full Text] [Related]
6. Note from the editor. Freedman R Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255 [No Abstract] [Full Text] [Related]
7. Notice of failure to disclose financial interest: "A neuropsychological test battery for use in Alzheimer disease clinical trials" (Arch Neurol. 2007;64[9]:1323-1329). Harrison J Arch Neurol; 2008 Jul; 65(7):992. PubMed ID: 18625878 [No Abstract] [Full Text] [Related]
8. Challenges in science and academic-industry interactions. Eisman JA; Lorenzo JA J Bone Miner Res; 2007 Nov; 22(11):1654-5. PubMed ID: 17931099 [No Abstract] [Full Text] [Related]
9. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
10. The sins of ghostwriting. Somberg JC Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328 [No Abstract] [Full Text] [Related]
11. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials. Roehr B BMJ; 2012 May; 344():e3767. PubMed ID: 22641830 [No Abstract] [Full Text] [Related]
12. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
13. Clinical trial publications. Bhatt AD Issues Med Ethics; 2000; 8(4):119-21. PubMed ID: 16323375 [No Abstract] [Full Text] [Related]
14. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
15. Ethical issues in the relationships involving medicine and industry. Thomas PS; Tan KS; Yates DH Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554 [No Abstract] [Full Text] [Related]
16. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics. Campbell MJ Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038 [No Abstract] [Full Text] [Related]
17. Medical ethics, research and the pharmaceutical industry. Abud-Mendoza C Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694 [No Abstract] [Full Text] [Related]
18. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
19. [Ghostwriting]. Haug C Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881 [No Abstract] [Full Text] [Related]
20. [Knowledge on feet of clay]. Dahlqvist R Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980 [No Abstract] [Full Text] [Related] [Next] [New Search]